Women with urinary incontinence can avoid invasive bladder pressure tests

Women with constant urinary incontinence can avoid invasive bladder pressure tests, because new studies show that a number of non -invasive assessments work equally well in treatment.

Managed by scientists from the University of Aberdeen, the findings of the future process are presented today (Saturday, March 22, 2025) at the European Congress of the Urology Association (Eau) in Madrid and published in Madrid and published in

The study in Great Britain is the world’s first randomized controlled clinical trial and the profitability of invasive urodynamic tests. It focuses on a group of women with specific types of overactive bladder or encourages urinary incontinence, which do not react well to initial treatment.

These first -line treatments include pelvic floor exercises, the retraining of the bladder and drug treatment, and the referral for invasive urodynamic tests can determine whether their condition is caused by an overactive detoxor muscle in the bladder. Tests are recommended by British and European guidelines before it goes to invasive procedures, such as the stimulation of the sacral nerve or injection of botulinum toxin directly in the bladder wall.

In the case of this group of women, invasive urodynamic tests have been widely used in clinical practice for over 40 years. He assesses how well he stores the bladder and releases urine and can be an uncomfortable test for many. The tests include the bladder filling by the catheter put into the bladder. Another catheter is inserted into the vagina or rectum to measure pressure inside the bladder and abdomen.

It is believed that a comprehensive clinical assessment (CCA) for women’s urinary incontinence reveals equally useful information to conduct treatment without the need for invasive testing. CCA includes a detailed medical questionnaire, a thorough physical examination, bladder diary and “cough test” to assess stress incontinence. This may also include urine analysis and test to measure the amount of urine left in the bladder after urination.

To determine whether urodynamic tests would lead to patients’ successful results from their treatment, compared to the treatment plans directed by CCA, in the future study 1099 women in 63 hospitals in Great Britain recruited.

Women were included in the study if they had an overactive bladder or urinary incontinence, mainly characterized by sudden urgency of urine, which did not react to the treatment of the first throw. Participants were randomly assigned to undergo invasive urodynamic tests plus CCA or only CCA.

In the 15-24-month observation period, participants were asked to report the success of the offered treatment. In the study, it did not show a significant difference between two forms of assessment, with 23.6% of women reporting that their symptoms were “very” and “significantly” improved in the group WEBODYNAMICS compared to 22.7% in the CCA group – which shows that both grades provide similar results reported by the patient.

Women who only underwent CCA have also reported an earlier improvement in their symptoms. 13% of women subjected to urodynamics turned into diagnosis to urinary urinary incontinence, and their treatment plan has changed accordingly.

Scientists suggest that clinicians can now be more selective in determining who to refer to invasive urodynamic tests.

Invasive urodynamic tests can be embarrassing and uncomfortable procedures. In the case of many women who are struggling with finding treatment that affects this type of urinary incontinence, our study shows that they no longer have to undergo experience to achieve improvement of their symptoms and quality of life.

While women who underwent invasive urodynamic tests received more adapted treatment based on the test result, this did not translate into better success indicators reported by the patient, a better improvement in the quality of life of women or less undesirable events.

It is obvious that in this group of women, comprehensive clinical assessments provide enough information to help design a successful treatment plan for people who do not respond to the treatment of the first throw, so clinicists can be much more selective about who is addressed to athodynamics. “

Professor Mohamed Abdel-Fattah, main researcher, director of Aberdeen Center for Women’s Health Research, University of Aberdeen

CCA can be carried out by a specialist nurse or hospital doctor and does not require specialized equipment. However, invasive WEBODYNAMICS tests include a referral to a specialized clinic, include several employees and dedicated equipment, and can mean waiting for many weeks or months.

After economic evaluation, scientists came to the conclusion that the urodynamic tests for this group of women were not used for money, based on the National Institute of the National Institute of Health and Care Perfection in the amount of $ 20,000 for an additional year of good health.

Commenting on the results of the future sample, Monster Benoit Peyronnet, a monans at the Urology Department of the University of Rennes, France and a member of the Scientific Eau Congress Office, said: “Many European countries have long lists waiting for urodynamic tests, and invasive tests can be an invisible experience for women. Patient subgroup and results for women – based on their own reports about whether their treatment has succeeded – may be equally good.

“However, in the occupied clinical conditions, there may not be time to undertake a series of comprehensive assessments carried out in a future study, so invasive urodynamic tests can still be valuable and important in some conditions-especially in some groups of patients. We must also think that this is only a two-year study based on patients reported results, and the evidence is enough to influence the fact that this will be a very interesting attempt to be very interesting. interesting to take action. “

The future study was financed by the National Institute for Health and Care Research Research Technology Assessment. Currently, a five -year observation period assessing long -term results and profitability of urodynamics.